Cargando…

Microspheres for Drug Delivery

With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of new, more potent and specific therapeutics are being created. Because of common problems such as low solubility, high potency, and/or poor stability of many of these new drugs, the means of drug delivery can imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyekyoon Kevin, Pack, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122341/
http://dx.doi.org/10.1007/978-0-387-25842-3_2
_version_ 1783515397414191104
author Kim, Kyekyoon Kevin
Pack, Daniel W.
author_facet Kim, Kyekyoon Kevin
Pack, Daniel W.
author_sort Kim, Kyekyoon Kevin
collection PubMed
description With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of new, more potent and specific therapeutics are being created. Because of common problems such as low solubility, high potency, and/or poor stability of many of these new drugs, the means of drug delivery can impact efficacy and potential for commercialization as much as the nature of the drug itself. Thus, there is a corresponding need for safer and more effective methods and devices for drug delivery. Indeed, drug delivery systems—designed to provide a therapeutic agent in the needed amount, at the right time, to the proper location in the body, in a manner that optimizes efficacy, increases compliance and minimizes side effects—were responsible for $47 billion in sales in 2002, and the drug delivery market is expected to grow to $67 billion by 2006.
format Online
Article
Text
id pubmed-7122341
institution National Center for Biotechnology Information
language English
publishDate 2006
record_format MEDLINE/PubMed
spelling pubmed-71223412020-04-06 Microspheres for Drug Delivery Kim, Kyekyoon Kevin Pack, Daniel W. BioMEMS and Biomedical Nanotechnology Article With advances in biotechnology, genomics, and combinatorial chemistry, a wide variety of new, more potent and specific therapeutics are being created. Because of common problems such as low solubility, high potency, and/or poor stability of many of these new drugs, the means of drug delivery can impact efficacy and potential for commercialization as much as the nature of the drug itself. Thus, there is a corresponding need for safer and more effective methods and devices for drug delivery. Indeed, drug delivery systems—designed to provide a therapeutic agent in the needed amount, at the right time, to the proper location in the body, in a manner that optimizes efficacy, increases compliance and minimizes side effects—were responsible for $47 billion in sales in 2002, and the drug delivery market is expected to grow to $67 billion by 2006. 2006 /pmc/articles/PMC7122341/ http://dx.doi.org/10.1007/978-0-387-25842-3_2 Text en © Springer Science + Business Media, LLC 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Kim, Kyekyoon Kevin
Pack, Daniel W.
Microspheres for Drug Delivery
title Microspheres for Drug Delivery
title_full Microspheres for Drug Delivery
title_fullStr Microspheres for Drug Delivery
title_full_unstemmed Microspheres for Drug Delivery
title_short Microspheres for Drug Delivery
title_sort microspheres for drug delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122341/
http://dx.doi.org/10.1007/978-0-387-25842-3_2
work_keys_str_mv AT kimkyekyoonkevin microspheresfordrugdelivery
AT packdanielw microspheresfordrugdelivery